Xi Zheng
Beijing, 100871, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Characteristics of CLA⁺Tregs in rheumatoid arthritis and their potential as biomarkers of treatment response.
Journal: Arthritis research & therapy
Published: September 25, 2025
Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis.
Journal: Science advances
Published: January 03, 2025
Rheumatoid arthritis patients harbour aberrant enteric bacteriophages with autoimmunity-provoking potential: a paired sibling study.
Journal: Annals of the rheumatic diseases
Published: January 22, 2024
A citrullinated antigenic vaccine in treatment of autoimmune arthritis.
Journal: Science bulletin
Published: December 25, 2023
Combination of scavenger receptor-A with anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: October 21, 2023
MDSCs are important osteoclast precursors primed by B cells in rheumatoid arthritis.
Journal: European journal of immunology
Published: October 11, 2023
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: August 19, 2023
Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis.
Journal: Annals of medicine
Published: August 17, 2023
Raman spectroscopy as a promising diagnostic method for rheumatoid arthritis.
Journal: Analytical methods : advancing methods and applications
Published: January 04, 2023
Serum Antigenome Profiling Reveals Diagnostic Models for Rheumatoid Arthritis.
Journal: Frontiers in immunology
Published: February 26, 2022
Casein Kinase II exacerbates rheumatoid arthritis via promoting Th1 and Th17 cell inflammatory responses.
Journal: Expert opinion on therapeutic targets
Published: November 22, 2021
SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis.
Journal: Clinical and experimental immunology
Published: July 02, 2021
Last Updated: 09/26/2026